secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2023-04-07T23:59:59+00:00
Accession:  0001437749-23-009713
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Windtree pre-announces $4.2M cash at Q1 end; net cash used $2.9M in Q1
----------------------------------------------------------------------

- Cash and cash equivalents estimated at ~$4.2 million as of March 31, 2023.
- Net cash used before financing activities for Q1 2023 was $2.9 million.
- These are preliminary estimates; final Q1 results may differ materially.
- Company's cash burn rate raises potential going-concern risk for micro-cap biotech.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774923009713/0001437749-23-009713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774923009713/wint20230406_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-009713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer